FHM LIFE Sciences Viii, LLC, 10% Owner, Director at Arcutis Biotherapeutics, Inc. (ARQT), bought 80,000 shares at $2.50 ($200K) on 2023-10-24, disclosed to the SEC on 2023-10-26.
Open-market purchase of $200k ARQT by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.